deltatrials
Terminated PHASE1 INTERVENTIONAL 3-arm NCT03035279

A Study of SC-006 and in Combination With ABBV-181 in Subjects With Advanced Colorectal Cancer

An Open Label Phase 1 Study of SC-006 as a Single Agent and in Combination With ABBV-181 in Subjects With Advanced Colorectal Cancer

Sponsor: AbbVie

Conditions Colorectal Cancer
Interventions ABBV-181 SC-006
Updated 19 times since 2017 Last updated: Feb 18, 2020 Started: Mar 8, 2017 Primary completion: Mar 28, 2019 Completion: Mar 28, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Strategic considerations

Other terminated trials from AbbVie

See all terminations from AbbVie

Other Colorectal Cancer trials with similar outcome

Browse all Colorectal Cancer trials

Listed as NCT03035279, this PHASE1 trial focuses on Colorectal Cancer and remains terminated or withdrawn. Sponsored by AbbVie, it has been updated 19 times since 2017, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Jun 2017 · 2 months · monthly snapshot~Jun 2017 – ~Dec 2017 · 6 months · monthly snapshot~Dec 2017 – ~Jan 2018 · 31 days · monthly snapshot~Jan 2018 – ~Mar 2018 · 59 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Jan 2019 · 3 months · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~May 2019 · 3 months · monthly snapshot~May 2019 – ~Mar 2020 · 10 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

19 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE1

  5. Mar 2020 — Jan 2021 [monthly]

    Terminated PHASE1

▶ Show 14 earlier versions

  1. May 2019 — Mar 2020 [monthly]

    Terminated PHASE1

    Status: Active Not Recruiting → Terminated

  2. Feb 2019 — May 2019 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  3. Jan 2019 — Feb 2019 [monthly]

    Recruiting PHASE1

  4. Oct 2018 — Jan 2019 [monthly]

    Recruiting PHASE1

  5. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE1

  6. Jul 2018 — Sep 2018 [monthly]

    Recruiting PHASE1

  7. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE1

  8. Apr 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

  9. Mar 2018 — Apr 2018 [monthly]

    Recruiting PHASE1

  10. Jan 2018 — Mar 2018 [monthly]

    Recruiting PHASE1

  11. Dec 2017 — Jan 2018 [monthly]

    Recruiting PHASE1

  12. Jun 2017 — Dec 2017 [monthly]

    Recruiting PHASE1

  13. Apr 2017 — Jun 2017 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  14. Feb 2017 — Apr 2017 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AbbVie
Data source: AbbVie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations